MEYER HANDELMAN CO - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
MEYER HANDELMAN CO ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$8,759,001
-17.2%
232,0880.0%0.35%
-17.3%
Q2 2023$10,573,929
+4.1%
232,088
-7.3%
0.43%
+0.5%
Q1 2023$10,156,062
-20.4%
250,3960.0%0.42%
-20.3%
Q4 2022$12,762,684
-12.8%
250,396
-7.9%
0.53%
-21.2%
Q3 2022$14,638,000
-16.1%
271,7960.0%0.68%
-9.7%
Q2 2022$17,457,000
-17.2%
271,7960.0%0.75%
-7.3%
Q1 2022$21,076,000
-9.9%
271,796
-0.2%
0.81%
-7.2%
Q4 2021$23,382,000
+9.1%
272,396
+2.3%
0.87%
-0.9%
Q3 2021$21,422,000
-0.1%
266,3520.0%0.88%
+3.8%
Q2 2021$21,440,000
-4.6%
266,3520.0%0.85%
-8.9%
Q1 2021$22,465,000
+6.7%
266,352
+1.5%
0.93%
-2.3%
Q4 2020$21,063,000
+3.1%
262,506
+3.3%
0.95%
-8.5%
Q3 2020$20,431,000
-6.6%
254,0610.0%1.04%
-10.8%
Q2 2020$21,874,000
+3.8%
254,061
-2.1%
1.17%
-9.8%
Q1 2020$21,066,000
-3.6%
259,461
-0.7%
1.29%
+23.3%
Q4 2019$21,844,000
-4.4%
261,2290.0%1.05%
-9.3%
Q3 2019$22,849,000
+6.6%
261,229
-0.2%
1.16%
+5.4%
Q2 2019$21,426,000
+9.0%
261,6290.0%1.10%
+7.2%
Q1 2019$19,654,000
+14.1%
261,6290.0%1.02%
+5.0%
Q4 2018$17,220,000
-14.6%
261,6290.0%0.97%
-1.1%
Q3 2018$20,168,000
+2.4%
261,629
-1.9%
0.98%
-2.5%
Q2 2018$19,702,000
+11.7%
266,829
-1.6%
1.01%
+12.5%
Q1 2018$17,637,000
-0.8%
271,173
-1.5%
0.90%
+5.4%
Q4 2017$17,787,000
-17.9%
275,173
-20.3%
0.85%
-13.9%
Q3 2017$21,659,000
+2.3%
345,173
-1.3%
0.99%
+10.6%
Q2 2017$21,173,000
+16.7%
349,733
-0.0%
0.90%
+15.8%
Q1 2017$18,139,000
+17.0%
349,7730.0%0.77%
+12.5%
Q4 2016$15,509,000
-1.2%
349,773
+6.1%
0.69%
-2.6%
Q3 2016$15,697,000
+4.6%
329,773
-0.6%
0.70%
+4.6%
Q2 2016$15,009,000
+8.1%
331,917
-1.8%
0.67%
+5.0%
Q1 2016$13,889,000
+7.5%
338,067
-0.2%
0.64%
+4.9%
Q4 2015$12,924,000
+16.5%
338,759
+0.3%
0.61%
+8.9%
Q3 2015$11,097,000
-53.1%
337,834
-0.1%
0.56%
-48.0%
Q2 2015$23,658,000
+1.9%
338,302
-0.1%
1.08%
+3.0%
Q1 2015$23,208,000
-6.5%
338,8020.0%1.05%
-5.9%
Q4 2014$24,831,000
+2.1%
338,8020.0%1.12%
-1.2%
Q3 2014$24,316,000
-0.8%
338,802
-0.1%
1.13%
-0.5%
Q2 2014$24,524,000
-1.7%
339,2020.0%1.14%
-5.3%
Q1 2014$24,960,000
+4.8%
339,202
-1.0%
1.20%
+3.9%
Q4 2013$23,819,000
+5.9%
342,4680.0%1.15%
-3.6%
Q3 2013$22,497,000
-5.3%
342,468
-0.2%
1.20%
-8.3%
Q2 2013$23,763,000343,0341.31%
Other shareholders
BAXTER INTL INC shareholders Q1 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders